| 2D Structure | |
| CID | 110673 |
| IUPAC Name | 1-[2-[(2-chlorophenyl)-phenylmethoxy]ethyl]-4-[(2-methylphenyl)methyl]piperazine;dihydrochloride |
| InChI | InChI=1S/C27H31ClN2O.2ClH/c1-22-9-5-6-12-24(22)21-30-17-15-29(16-18-30)19-20-31-27(23-10-3-2-4-11-23)25-13-7-8-14-26(25)28;;/h2-14,27H,15-21H2,1H3;2*1H |
| InChI Key | ZTACEXAAXMFRGD-UHFFFAOYSA-N |
| Canonical SMILES | None |
| Isomeric SMILES | None |
| Molecular Formula | C27H33Cl3N2O |
| Molecular Weight | 507.9 |
| synonyms | ['Chlorbenzoxamine hydrochloride', 'Gastomax', 'Chlorbenzoxamine HCl', 'Chlorbenzoxamine dihydrochloride', 'Antiulcera master', 'Libratar dihydrochloride', 'Auy-I', 'UCB 1474', '5576-62-5', 'Chlorobenzoxamin dihydrochloride', 'Chlorobenzoxamine dihydrochloride', 'Chlorbenzoxyethamine dihydrochloride', 'EINECS 226-951-3', 'NSC 169098', 'UNII-I898I67K6S', 'I898I67K6S', 'UCB-1474', 'NSC-169098', 'Piperazine, 1-(2-((2-chlorophenyl)phenylmethoxy)ethyl)-4-((2-methylphenyl)methyl)-, 2HCl', 'CHLORBENZOXAMINE DIHYDROCHLORIDE [MI]', 'CHLORBENZOXAMINE HYDROCHLORIDE [MART.]', 'CHLORBENZOXAMINE HYDROCHLORIDE [WHO-DD]', 'Piperazine, 1-(2-((o-chloro-alpha-phenylbenzyl)oxy)ethyl)-4-(o-methylbenzyl)-, dihydrochloride', 'NSC169098', 'CHLORBENZOXAMINE HYDROCHLORIDE (MART.)', 'RefChem:125294', '1-(2-(o-Chloro-alpha-phenylbenzyloxy)ethyl)-4-o-methylbenzylpiperazine Hydrochloride', '226-951-3', 'Piperazine, 1-(2-((2-chlorophenyl)phenylmethoxy)ethyl)-4-((2-methylphenyl)methyl)-, 2HCl (9CI)', '1-[2-[(2-CHLOROPHENYL)PHENYLMETHOXY]ETHYL]-4-[(O-TOLYL)METHYL]PIPERAZINE DIHYDROCHLORIDE', '1-(2-((2-Chlorophenyl)phenylmethoxy)ethyl)-4-((o-tolyl)methyl)piperazine dihydrochloride', 'CHEMBL3989550', 'SCHEMBL21807723', 'ZTACEXAAXMFRGD-UHFFFAOYSA-N', 'DTXSID801371272', '1-(2-(o-Chloro-alpha-phenylbenzyloxy)ethyl)-4-o-methylbenzylpiperazine dihydrochloride', 'NS00080543', 'Q27280569'] |
From Pubchem